Pentasa 1 G Enema 1 g Suspension

Pentasa 1 G Enema 1 g Suspension

S3
PDF Leaflet Revision Date: 09 January 2015

API: Mesalazine | Company: Ferring

Clinical Summary

Quick overview from the medicine insert

Indication

Treatment of ulcerative proctosigmoiditis and left-sided colitis.

Dosage (summary)

One enema at bedtime.

Special Populations

  • Renal impairment
  • Hepatic impairment

Pregnancy & Breastfeeding

Safety not established; may cause blood disorders in newborns; breastfeeding not recommended.

Key Drug Interactions

  • Azathioprine
  • 6-mercaptopurine

Contraindications

  • Hypersensitivity to components
  • Severe liver impairment
  • Severe renal impairment

Common side effects

  • Diarrhoea
  • Nausea
  • Abdominal pain
  • Headache
  • Vomiting
  • Rash

Counselling Points

  • Insert rectally, do not ingest
  • Shake before use
  • Use immediately after opening

Serious warnings

  • Risk of blood dyscrasias
  • Monitor liver function
  • Monitor renal function
Important Disclaimer

The Pentasa 1 G Enema 1 g Suspension professional information leaflet below is the property of Ferring and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>

Healthcare Professionals Only

This content is for registered healthcare professionals

Sign in or create a free account to read the full package insert.

Free for HPCSA-registered professionals. Powered by Medinsert.

Successfully Stashed! 💊

This package insert has been safely stored in your digital medical cabinet. No prescription needed to view it later!

View My Favourites